Synthesis of Tailor‐Made Glycoconjugates Showing AT III‐Mediated Inhibition of Blood Coagulation Factors Xa and Thrombin
- 16 February 1996
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition in English
- Vol. 35 (3) , 331-333
- https://doi.org/10.1002/anie.199603311
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activityNature Structural & Molecular Biology, 1995
- Die charakteristische AT‐III‐Bindungsregion in Heparin: eine Leitstruktur für neue synthetische AntithromboticaAngewandte Chemie, 1993
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie International Edition in English, 1993
- A Short Synthetic Route towards a Biologically Active Heparin‐like Pentasaccharide with a Pseudo‐Alternating SequenceAngewandte Chemie International Edition in English, 1993
- Kurze Synthese eines biologisch aktiven, Heparin-ähnlichen Pentasaccharids mit pseudo-alternierender SequenzAngewandte Chemie, 1993
- Biologically active heparin-like fragments with a “non-glycosamino”glycan structure. Part 3 : o-alkylated-o-sulphated pentasaccharides.Bioorganic & Medicinal Chemistry Letters, 1992
- Constructing a molecular model of the interaction between antithrombin III and a potent heparin analogJournal of the American Chemical Society, 1991
- New Methods for the Synthesis of Glycosides and Oligosaccharides—Are There Alternatives to the Koenigs‐Knorr Method? [New Synthetic Methods (56)]Angewandte Chemie International Edition in English, 1986
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARINAnnals of the New York Academy of Sciences, 1981